Nucleic Acid Polymer Particles for High-Density Amplicon Loading

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for generating signal in genomics and biomedical research, such as hybrid selection, in-gel PCR, and emulsion PCR, face limitations including low fragment density, labor-intensive emulsion reactions, and unsuitable particulate supports for exacting applications like large-scale DNA sequencing.

Innovation Solution

The development of nucleic acid polymer particles with non-nucleosidic polymer networks that have high primer concentrations and controlled size distributions, allowing for enhanced analyte binding and amplification reactions without the need for emulsion reactions, providing higher fragment concentrations and uniformity.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If traditional bead supports are used for amplicon attachment, then spatial concentration of amplicons is achieved, but fragment density and signal-to-noise ratio are insufficient

Engineering Contradiction:
Improvefragment densityVSAvoidsignal-to-noise ratio
Core Design Contradiction:
Quantity of substanceVSMeasurement precision

Solution Approach 1:

The patent employs porous polymer particles with controlled pore sizes (5-50 nm) that allow high-density attachment of amplicons throughout the particle volume. The porous structure provides extensive internal surface area while maintaining small external dimensions (1-30 μm), enabling high fragment density without increasing particle size, thus improving signal-to-noise ratio.

Inventive Principle:
Principle #31Porous materials

Solution Approach 2:

The invention transitions from two-dimensional surface attachment on traditional beads to three-dimensional volume-based attachment in porous particles. Amplicons can be attached throughout the entire particle volume including internal pores, effectively utilizing three-dimensional space to increase fragment density while maintaining small particle dimensions for high signal-to-noise ratio.

Inventive Principle:
Principle #17Another dimension (Dimensionality change)

2Reliability

If emulsion PCR is used to obtain clonal populations, then clonal amplification is achieved, but the process becomes labor intensive and costly

Engineering Contradiction:
Improveclonal population purityVSAvoidprocess complexity
Core Design Contradiction:
ReliabilityVSEase of manufacture

Solution Approach 1:

The patent extracts the essential function of emulsion PCR (clonal amplification) and implements it through a simplified solid-phase bridge amplification process on porous particles. By removing the complex emulsion formation and manipulation steps while retaining the clonal amplification capability through controlled primer attachment and amplification conditions, the process becomes less labor-intensive and more cost-effective.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The porous polymer particles serve as intermediaries that facilitate clonal amplification without requiring emulsion conditions. The particles provide a solid-phase support with controlled primer distribution that enables clonal amplification through bridge PCR, acting as a mediator between the template DNA and the amplification reaction, thereby eliminating the need for complex emulsion handling.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Ease of operation

If gel particulates with varying size distributions are used, then analytical reagent access is improved, but suitability for exacting applications like DNA sequencing is reduced

Engineering Contradiction:
Improvereagent accessVSAvoidsize uniformity
Core Design Contradiction:
Ease of operationVSManufacturing precision

Solution Approach 1:

The patent employs controlled polymerization conditions including specific monomer concentrations, crosslinker ratios, and polymerization temperatures to produce porous particles with narrow size distributions (coefficient of variation <10%). This precise control of size parameters maintains manufacturing precision while the porous structure ensures adequate reagent access throughout the particle volume.

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention creates particles with non-uniform internal structure (porous) combined with uniform external dimensions. The local porosity provides reagent access throughout the particle volume while the uniform external size ensures manufacturing precision and consistency for exacting applications like DNA sequencing. Different regions of the particle have different properties: uniform size externally, porous internally.

Inventive Principle:
Principle #3Local quality

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enhances the sensitivity and efficiency of nucleic acid analysis by creating monodisperse populations of gel-based particulate supports, improving signal-to-noise ratios and reducing costs through easier handling and reagent access.

Implementation Method 1

each such particle comprising a non-nucleosidic polymer network having attached throughout its volume a primer at a concentration of at least 1 × 10^5 primers per particle

Methodology Applied
Scientific EffectAdsorption: Adsorption

Data Source

PatentEP3663750B1Scaffolded nucleic acid polymer particles and methods of making and using
Publication Date: 2021.11.03 LIFE TECHNOLOGIES CORP
  • EP3663750B1 patent drawingFigure 1A~1B
  • EP3663750B1 patent drawingFigure 2A
  • EP3663750B1 patent drawingFigure 2B

AI summary

The invention provides particle compositions having applications in nucleic acid analysis. Nucleic acid polymer particles of the invention allow polynucleotides to be attached throughout their volumes for higher loading capacities than those achievable solely with surface attachment. In one aspect, nucleic acid polymer particles of the invention comprise polyacrylamide particles with uniform size distributions having low coefficients of variations, which result in reduced particle-to-particle variation in analytical assays. Such particle compositions are used in various amplification reactions to make amplicon libraries from nucleic acid fragment libraries.